Allogeneic umbilical cord mesenchymal stem cell therapy (Ever Supreme Bio Technology Co., Ltd.)

N/A

Report date: 2023/01/12 15:30:28

Base Information

Drug NameAllogeneic umbilical cord mesenchymal stem cell therapy (Ever Supreme Bio Technology Co., Ltd.)
Drug Alias NameAllogeneic umbilical cord mesenchymal stem cells同种异体脐带间充质干细胞疗法-长圣国际生技股份有限公司UMSC-01
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)ST Elevation Myocardial InfarctionMyocardial Infarction +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEver Supreme Bio Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEver Supreme Bio Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)ST Elevation Myocardial InfarctionMyocardial Infarction +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A